• Español
Logotipo BioKeralty
  • Home
  • BioKeralty
  • Areas and lines of research
  • Projects
  • Resources
  • Contact
/ Resources / News / BioKeralty searches for innovative solutions able to optimize the manufacture of cornea substitutes

BioKeralty searches for innovative solutions able to optimize the manufacture of cornea substitutes

Oct 01 2022
adminbk 0 Comments

BioKeralty news

BioKeralty searches for innovative solutions able to optimize the manufacture of cornea substitutes

The initiative is part of the Nanogrow project which seeks to shorten manufacturing times and increase the effectiveness and tolerance of autograft

In the image, lipid nanoparticles (NLC) with growth factors.

December 15, 2021

Started in 2017, the goal of the Nanogrow project has been focused on the optimization of cornea substitutes’ industrial manufacture in cell therapy. Specifically, the project has been centered in the development of new innovative proposals to obtain tissue substitutes using nanoparticles containing growth factors. In this way, the project seeks to promote cell multiplication in order to shorten manufacturing times and increase the effectiveness and tolerance of autograft.


Cell therapy and nanotechnology combination as a promising proposal


In this context, Keralty took part in the presentation of innovative proposals oriented to improve the extraction and purification of human plasma growth factors, increasing its biocompatibility for future human application. More in detail, Keralty’s work was focused on the optimization process of growth factors’ release defining the extraction process of those growth factors from plasma samples. In addition, it was also in charge of the formulation of lipid nanoparticles (NLC) including growth factors. To this aim, nanoparticle stability studies were carried out keeping the samples at -80°C during nine and twelve months in order to verify the stability of NLCs. However, in vitro studies were also developed using human fibroblasts to analyze their effect on cell viability and the wound healing process.

Financed by the Spanish Ministry of Science, Innovation and Universities, the Nanogrow project has been developed by the following partners: AJL Ophthalmic S.A., OSI Health XXI S.L.U., Karuna GCT S.L., Fundación Progreso y Salud/Andalusian Initiative in Advanced Therapies, University of the Basque Country, Higher Center for Scientific Research/Mediterranean Institute for Advanced Studies.

NanoGSkin reduces grafting time thanks to a regenerative approach

Prev Post
More news
NanoGSkin reduces grafting time thanks to a regenerative approach
by adminbk 09/30/2022
BioKeralty develops a predictive software for diabetes and cognitive impairment
by adminbk 07/30/2021
Completion of OSASUKAT, a blockchain platform project with a system designed by BioKeralty
by adminbk 07/26/2021
Key role of BioKeralty in the NoCanTher project which tests the implementation of magnetic nanoparticles in the treatment of pancreatic cancer
by adminbk 02/25/2021
BioKeralty present in the European project Smart4Fabry final round table next February 3
by adminbk 01/11/2021

Scientific resources

Patents and publications

For those people interested in the scientific publications and patents developed by the BioKeralty team, this section gathers detailed information and useful references corresponding to its scientific research.

Nanomaterials, biomedical applications, in vitro and in vivo antimicrobial activities, nanomedicine, fatty acids, nanofibrous membranes, tissue reparations, etc. constitute some of the research topics included in this section.

Awesome Image

  • C/Albert Einstein 25, Edificio E-3, 1ª planta Oficina 2

    Parque Tecnológico de Álava,

    01510 Miñano, Vitoria-Gasteiz (Álava), España

  • BioKeralty
  • Areas and lines of research
  • Projects
  • Resources
  • Legal
  • Privacy policy
  • Cookies policy
  • Contact

Copyright © BioKeralty 2023

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

BIOKERALTY
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.